Revance Therapeutics is covered by the following analysts.
|Barclays||Balaji Prasad MD|
|BNP Paribas Exane||Navann Ty|
|Cowen and Company||Ken Cacciatore|
|Goldman Sachs||Chris Shibutani|
|H.C. Wainwright||Doug Tsao|
|Mizuho||Vamil Divan, MD|
|Morgan Stanley||Terence Flynn|
|Piper Sandler||David Amsellem|
|William Blair||Tim Lugo|
|Wells Fargo||Jacob Hughes|
Revance Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Revance Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Revance Therapeutics, Inc. or its management. Revance Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.